Naive T-cell depletion in stem cell transplantation

Area of Science:

• Immunology
• Hematology
• Transplantation Medicine

Background:

• Allogeneic hematopoietic stem cell transplantation (HCT) offers a cure for advanced hematopoietic malignancies.
• Donor T cells are crucial for engraftment and disease control but can cause graft-versus-host disease (GVHD).
• Complete T-cell depletion reduces GVHD but impairs immune reconstitution and increases infection/relapse risks.

Purpose of the Study:

• To evaluate the efficacy and safety of naive T-cell (TNs)-depleted peripheral blood stem cell (PBSC) grafts in HCT.
• To assess the impact of TN depletion on GVHD, immune reconstitution, opportunistic infections, and relapse rates.
• To investigate strategies for retaining graft-versus-leukemia function in TN-depleted HCT.

Main Methods:

• Clinical trials evaluating TN-depleted PBSC grafts in HLA-matched HCT settings.
• Murine models of HCT to understand the role of T-cell subsets in GVHD and graft-versus-tumor activity.
• Correlative laboratory studies to analyze antitumor function retention in TN-depleted HCT.

Main Results:

• TN-depleted PBSC grafts show very low rates of chronic and acute GVHD in HLA-matched HCT.
• These grafts result in lower frequencies of opportunistic infections compared to fully T-cell-depleted HCT.
• No apparent increase in relapse rates was observed with TN-depleted grafts.

Conclusions:

• Naive T-cell depletion is a promising strategy to reduce GVHD while preserving antitumor immunity in HCT.
• This approach enhances immune reconstitution and lowers infection rates, improving HCT safety.
• Further research is ongoing to optimize TN depletion and augment graft-versus-leukemia effects.